Janus Henderson Group PLC Nuvasive Inc Transaction History

Janus Henderson Group PLC

$178 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.71 - $44.15 $35,939 - $43,222	979 Added 0.13%	773,313 $32.2 Million
Q1 2023 May 15, 2023	BUY	$36.81 - $48.12 $7.41 Million - $9.69 Million	201,414 Added 35.28%	772,334 $31.9 Million
Q4 2022 Feb 14, 2023	BUY	$35.68 - $44.71 $20 Million - $25.1 Million	560,481 Added 5369.11%	570,920 $23.5 Million
Q3 2022 Nov 14, 2022	BUY	$42.51 - $54.02 $935 - $1,188	22 Added 0.21%	10,439 $457,000
Q2 2022 Aug 15, 2022	SELL	$46.84 - $59.75 $796 - $1,015	-17 Reduced 0.16%	10,417 $511,000

Q1 2022 May 16, 2022	BUY	$48.09 - $57.79 $48 - $57	1 Added 0.01%	10,434 $590,000
Q4 2021 Feb 14, 2022	BUY	$47.19 - $62.68 $247,605 - $328,881	5,247 Added 101.18%	10,433 $548,000
Q3 2021 Nov 16, 2021	BUY	$56.91 - $67.81 $295,135 - $351,662	5,186 New	5,186 $310,000
Q1 2019 Apr 30, 2019	SELL	$44.53 - $58.9 $1.86 Million - $2.46 Million	-41,810 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$47.64 - $71.26 $77.8 Million - $116 Million	-1,632,916 Reduced 97.5%	41,810 $2.07 Million
Q3 2018 Nov 09, 2018	SELL	$52.03 - $71.41 $21.6 Million - $29.6 Million	-414,324 Reduced 19.83%	1,674,726 $119 Million
Q2 2018 Aug 10, 2018	SELL	$48.15 - $56.68 $17.8 Million - $21 Million	-370,226 Reduced 15.05%	2,089,050 $109 Million
Q1 2018 May 14, 2018	BUY	$46.03 - $61.28 $95.1 Million - $127 Million	2,066,806 Added 526.62%	2,459,276 $128 Million
Q4 2017 Feb 09, 2018	BUY	$50.58 - $60.79 $8.44 Million - $10.1 Million	166,815 Added 73.92%	392,470 $23 Million
Q3 2017 Nov 14, 2017	BUY	$53.54 - $68.0 $3.31 Million - $4.2 Million	61,742 Added 37.67%	225,655 $0
Q2 2017 Aug 17, 2017	BUY	N/A	163,913	163,913 $12.6 Million

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account